John E. Sagartz - 18 Jan 2023 Form 4 Insider Report for Inotiv, Inc. (NOTV)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Jan 2023, 15:07:58 UTC
Prior SEC filing
17 Feb 2022
Next SEC filing
16 Mar 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Beth Taylor, Attorney-in-Fact for John Sagartz

Key filing fact

John E. Sagartz filed Form 4 for Inotiv, Inc. (NOTV) on 20 Jan 2023.

Key facts

  • This page summarizes John E. Sagartz's Form 4 filing for Inotiv, Inc. (NOTV).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Jan 2023, 15:07.

Change

  • Previous filing in this sequence was filed on 17 Feb 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NOTV transaction

Common Stock

Award

Transaction value
$0
Shares
+5,917
Change %
+0.87%
Price
$0.000000
Shares after
686,947
Date
18 Jan 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of restricted stock units, which vest in full on the second anniversary of the grant date, subject to continued employment.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .